title: Marketing drugs too early in testing.
authors.forename: Colin B
authors.initials: CB
authors.lastname: Begg
authors.forename: Otis
authors.initials: O
authors.lastname: Brawley
authors.forename: Robert M
authors.initials: RM
authors.lastname: Califf
authors.forename: David L
authors.initials: DL
authors.lastname: Demets
authors.forename: Susan S
authors.initials: SS
authors.lastname: Ellenberg
authors.forename: Richard S
authors.initials: RS
authors.lastname: Kaplan
mesh_terms: D017321:Clinical Trials, Phase I as Topic; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D006801:Humans; D007880:Legislation, Drug; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*